Skip to main content

Featured

Oil Just Hit $110 — Could Canada's Energy Boom Offset the Tariff Pain?

  Published September 13, 2026 · 6 min read Brent crude touched nearly $110 US a barrel when trading opened Friday morning — its highest level since the spring — as renewed Iran-linked strikes on Saudi energy infrastructure rattled global supply. It settled back down to close the week around $104.61, but the direction of travel has been unmistakable: oil is up roughly 9-10% in the past week alone. That's bad news at the pump. But according to a CBC News analysis published this morning, it might not be bad news for Canada's economy overall. The argument: the roughly 0.5% hit to GDP from Trump's tariffs could be more than offset by the windfall Canada earns as one of the world's biggest oil exporters. For a personal finance reader, that's really two separate stories — one that costs you money, and one that might be quietly making some of your money back. Here's how to think about both sides of your own ledger. Why oil is spiking again The latest leg up traces to ...

article

NDP and Liberals Reach Historic Pharmacare Deal: What You Need to Know

 


In a significant development, the federal New Democratic Party (NDP) and the Liberal government have come to an agreement on pharmacare, marking a crucial milestone in Canadian healthcare. Here’s a concise breakdown of what this deal entails:

  1. Universal Access: Every Canadian with a valid health card will gain access to essential medications without financial barriers.

  2. Free Diabetes Medication: The agreement includes coverage for diabetes treatment, ensuring that those living with diabetes can manage their condition effectively.

  3. Birth Control Coverage: As part of the initial phase of the national pharmacare program, contraception will be covered. This move aims to enhance reproductive health and empower individuals to make informed choices.

  4. Historic Significance: NDP Leader Jagmeet Singh emphasized the historic nature of this achievement. Canadians can now look forward to improved access to vital medications, regardless of their socioeconomic status.

The draft legislation, which outlines the framework for pharmacare, is set to be introduced soon. This deal not only strengthens the confidence-and-supply agreement between the two parties but also reflects a commitment to better healthcare for all.

Comments